Drug Shortage Report for APO-TERAZOSIN

Last updated on 2018-07-31 History
Report ID 36350
Drug Identification Number 02234505
Brand name APO-TERAZOSIN
Common or Proper name TERAZOSIN
Company Name APOTEX INC
Active Ingredient(s) TERAZOSIN
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-15
Estimated end date 2018-07-30
Actual end date 2018-07-30
Shortage status Resolved
Updated date 2018-07-31
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2018-07-31 French Compare
v13 2018-07-31 English Compare
v12 2018-07-31 French Compare
v11 2018-07-31 English Compare
v10 2018-07-25 French Compare
v9 2018-07-25 English Compare
v8 2018-07-04 French Compare
v7 2018-07-04 English Compare
v6 2018-04-02 French Compare
v5 2018-04-02 English Compare
v4 2018-02-12 French Compare
v3 2018-02-12 English Compare
v2 2018-01-17 French Compare
v1 2018-01-17 English Compare